EXPE
74
2
NFLX
55
-3
NWL
32
-3
ADP
70
-3
ETR
68
-3
MCHP
42
-5
MA
65
-4
TRV
64
-3
PM
52
-4
PYPL
45
-2
SE
65
4
ES
55
-5
PBI
62
2
MRK
53
3
VZ
45
-2
IFF
60
-3
SBUX
41
-3
VRTX
56
-4
AKAM
56
-2
PLD
51
-5
EXPE
74
2
NFLX
55
-3
NWL
32
-3
ADP
70
-3
ETR
68
-3
MCHP
42
-5
MA
65
-4
TRV
64
-3
PM
52
-4
PYPL
45
-2
SE
65
4
ES
55
-5
PBI
62
2
MRK
53
3
VZ
45
-2
IFF
60
-3
SBUX
41
-3
VRTX
56
-4
AKAM
56
-2
PLD
51
-5
Financhill
Back

Phathom Pharmaceuticals Quote, Financials, Valuation and Earnings

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

PHAT
Phathom Pharmaceuticals

Last Price:
18.71
Seasonality Move:
-9.67%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Phathom Pharmaceuticals Price Quote

$18.71
-0.54 (-2.81%)
(Updated: September 19, 2024 at 5:50 PM ET)

Phathom Pharmaceuticals Key Stats

Buy
62
Phathom Pharmaceuticals (PHAT) is a Buy
Day range:
$18.31 - $19.54
52-week range:
$6.07 - $19.68
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
1M
1-year change:
58.96%
Market cap:
$1.3B
Revenue:
$682K
EPS:
$-5.19

How Much Does Phathom Pharmaceuticals Make?

Data Unavailable

Is Phathom Pharmaceuticals Growing As A Company?

Data Unavailable

Phathom Pharmaceuticals Stock Price Performance

What Is Phathom Pharmaceuticals 52-Week High & Low?

Phathom Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Phathom Pharmaceuticals?

Is Phathom Pharmaceuticals Cash Flow Positive?

  • What Is PHAT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$215.5M
  • What Is Phathom Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $246.7M
  • What Is Phathom Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.5M

Phathom Pharmaceuticals Return On Invested Capital

Data Unavailable

Phathom Pharmaceuticals Earnings Date & Stock Price

Phathom Pharmaceuticals Competitors

Phathom Pharmaceuticals Dividend Yield

Phathom Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -0.81%
Revenue: 0% 28.25%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 22.57
Upside from Last Price: 17.25%

Major Shareholders

  • How many PHAT shares are owned by institutional investors?
    65.3M PHAT shares are owned by institutional investors
  • How many PHAT shares are owned by insiders?
    3.5M PHAT shares are owned by insiders